MARCKS and breast cancer: A landmark study by Ono et al.85showed that exosomal miR-23b, transferred from bone marrow-derived MSCs to metastatic BM2 breast cancer cells, induced dormancy with reduced proliferation, invasion, and chemotherapy sensitivity by targeting MARCKS.